Summary
Definition
History and exam
Key diagnostic factors
- coronary artery disease
- tachycardia
- hypotension
Other diagnostic factors
- weak pulse
- syncope
- presyncope
- airway compromise
- impaired consciousness
- lightheadedness
- dizziness
- diminished responsiveness
- chest discomfort
- dyspnea
- asymptomatic
Risk factors
- coronary artery disease
- acute myocardial infarction
- left ventricular systolic dysfunction
- hypertrophic cardiomyopathy
- long QT syndrome
- short QT syndrome
- Brugada syndrome
- sleep-disordered breathing (SDB)
- family history of sudden death
- mental or physical stress
- ventricular pre-excitation
- arrhythmogenic right ventricular cardiomyopathy
- electrolyte imbalance
- drug toxicity
- Chagas disease and other cardiomyopathies
Diagnostic tests
1st tests to order
- ECG
- transthoracic echocardiogram
- electrolytes
- troponin I
Tests to consider
- cardiac catheterization
- cardiac MRI
- electrophysiologic (EP) study
- genetic testing
Treatment algorithm
hemodynamically unstable ventricular tachycardia with a pulse
torsades de pointes
catecholaminergic polymorphic ventricular tachycardia
hemodynamically stable nonidiopathic sustained ventricular tachycardia
hemodynamically stable idiopathic sustained ventricular tachycardia
nonidiopathic: at high risk for ventricular tachycardia or history of sustained ventricular tachycardia/cardiac arrest without identifiable reversible cause
idiopathic ventricular tachycardia
Contributors
Authors
Sei Iwai, MD, FACC, FHRS
Professor of Clinical Medicine
New York Medical College
Section Chief, Cardiac Electrophysiology
Westchester Medical Center Health Network
Valhalla
NY
Disclosures
SI is an author of some references cited in this topic.
Acknowledgements
Professor Sei Iwai would like to gratefully acknowledge Dr Kenneth Stein and Dr Richard Keating, previous contributors to this topic.
Disclosures
KS declares he is an employee of and shareholder in Boston Scientific, a manufacturer of implantable cardioverter defibrillators and ablation catheters. RK declares that he has no competing interests.
Peer reviewers
Suneet Mittal, MD
Director
Electrophysiology Laboratory
The St. Luke's-Roosevelt Hospital Center
New York
NY
Disclosures
SM declares that he has no competing interests.
Kenneth A. Ellenbogen, MD
Kontos Professor of Cardiology
Medical College of Virginia
Richmond
VA
Disclosures
KAE declares that he has no competing interests.
Kim Rajappan, MA, MD, MRCP
Consultant Cardiologist and Electrophysiologist
Cardiac Department
John Radcliffe Hospital
Oxford
UK
Disclosures
KR declares that she has no competing interests.
Differentials
- Supraventricular tachycardia with aberrancy
- Supraventricular tachycardia with preexcitation
- Electrical artifact
More DifferentialsGuidelines
- 2024 AHA/ACC/AMSSM/HRS/PACES/SCMR guideline for the management of hypertrophic cardiomyopathy
- 2024 AHA/ACC/AMSSM/HRS/PACES/SCMR guideline for the management of hypertrophic cardiomyopathy
More Guidelines- Log in or subscribe to access all of BMJ Best Practice
Use of this content is subject to our disclaimer